For laboratory research use only — not for human consumption
For laboratory research use only — not for human consumption
Comparison
A neutral, structural comparison of MOTS-c and TB-500 as research compounds — written for researchers evaluating the two. It describes structure and research context only; it makes no human-use, dosing, or therapeutic claim. Both are supplied for in-vitro laboratory research use only.
| MOTS-c | TB-500 | |
|---|---|---|
| Class | Mitochondrial-derived peptide | Synthetic thymosin β4 fragment |
| Research area | Mitochondrial-peptide research | Actin-signalling & fragment-peptide research |
| CAS number | 1627580-64-6 | 77591-33-4 |
| Molecular formula | C101H152N28O22S2 | C212H350N56O78S |
| Sequence | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg | — |
| HPLC purity | 99% | 99.02% |
MOTS-c is a mitochondrial-derived peptide (encoded within the mitochondrial genome) studied in laboratory research into mitochondrial and metabolic-signalling pathways. As one of the better-characterised mitochondrial-derived peptides, it is a frequent reference compound in this emerging research area.
TB-500 is a synthetic fragment peptide related to thymosin β4, used in laboratory research into actin-binding and cell-migration signalling. Its fragment structure makes it a common comparator to full-length peptides in research settings.
Both compounds are supplied strictly for in-vitro laboratory research use only. Not for human or veterinary use. This comparison is structural and contextual and does not constitute advice on use.
